Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania

About this trial

This study aims to evaluate the THRIVE clinical pathway at HUP, focusing on supporting Medicaid-insured individuals, including those with serious mental illness, following hospitalization. The study will assess clinician/administrator perspectives on the pathway's feasibility, appropriateness, and acceptability and analyze referral patterns and post-discharge outcomes.

The objectives are:

1. To conduct a qualitative study evaluating the implementation of THRIVE, particularly its adaptation to include patients with serious mental illness. 2. To examine referral patterns, 30-day readmission rates, and ED utilization for THRIVE participants, comparing them with those receiving standard care.

Participants will be referred to home care services during hospitalization and seen by a home care nurse within 48 hours post-discharge. A discharging physician or Advanced Practice Provider will oversee care for 30 days or until a primary care or specialist visit. The Care Coordination Team will hold weekly case conferences for 30 days post-discharge to address both health and mental health needs. The study will compare outcomes of Medicaid-insured patients, including those with serious mental illness, to those receiving usual care.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Medicaid insured

Residing in the state of Pennsylvania

Experienced a hospitalization at study hospital

Agrees to home care at partner home care setting.

Disqualifiers

Individuals under age 18

Trial design

Design model

Parallel

Treatments tested in this trial

  • Thrive Intervention

    Behavioral

    • The THRIVE Clinical Pathway is a standardized transitional care clinical pathway that supports Medicaid insured or Medicaid eligible individuals being managed for both chronic diseases and serious mental illness following hospitalization.

Treatment groups

267 Participants
are divided into 2 treatment groups
Group A: THRIVE InterventionExperimental treatment 1 intervention
Group B: Usual CareNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Rates of Referrals to Homecare

We will evaluate changes in home care referrals between case managers exposed to the intervention compared to those who were not

Time frame
Through study completion, an average of 18 months
2

Rates of Readmissions

We will evaluate the rate of readmissions over the course of the study for THRIVE participants compared to those receiving usual care

Time frame
30 days following hospital discharge
3

Rates of Emergency Department Visit

We will evaluate the rate of ED visits over the course of the study for THRIVE participants compared to those receiving usual care.

Time frame
30 days following hospital discharge
4

Primary Care or Specialist Visit

We will compare the rates of primary care provider and specialist visits within 30 days following discharge compared to those receiving usual care

Time frame
30 Days following hospital discharge

Secondary outcomes

1

Feasibility, Acceptability, Appropriateness, Workload

We will conduct interviews of clinicians at the conclusion of the study to gather perceptions of the THRIVE clinical pathway and facilitators and barriers to engaging with the intervention

Time frame
Through study completion, an average of 18 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pennsylvania

Lead sponsor

Agency for Healthcare Research and Quality (AHRQ)

Collaborator